AFT — AFT Pharmaceuticals Share News
0.000.00%
Last trade - 00:00- NZ$482.38m
- NZ$525.04m
- NZ$254.71m
Brief: AFT Pharmaceuticals Sees To Extend Its Growth Record In FY26
Brief: AFT Pharmaceuticals Posts FY Revenue Of NZ$208 Million
Brief: Zhaoke Ophthalmology Announces Distribution Agreement With AFT Pharmaceuticals
Brief: AFT Pharmaceuticals Expect To Achieve Record Sales Of More Than NZ$200M In FY25
Brief: Aft Pharmaceuticals Sees Operating Profit For Year To Range Between NZ$15 Mln To NZ$20 Mln
NZ's AFT Pharmaceuticals falls most in over 5 months on expected first-half loss
Brief: AFT Pharmaceuticals Sees Operating Loss Of Just Under NZ$2 Mln For HY
Brief: AFT Pharmaceuticals Enters Late-Stage R+D Agreement For Novel Injectable
NZ'S AFT Pharmaceuticals gains on partnering for injectable launch
Brief: AFT Pharmaceuticals Announces Exclusive Licensing Of Maxigesic IV
NZ's AFT Pharmaceuticals gains on deal to distribute pain management tablets in US
Brief: AFT Pharmaceuticals Announces Agreement With Hikma Pharmaceuticals USA
Brief: Aft Pharmaceuticals Agrees Distribution For Crystaderm In China
NZ's AFT Pharmaceuticals gains on launch of non-opioid pain management solution in US
Brief: Aft Pharmaceuticals Says To Launch Maxigesic Rapid In United States
New Zealand's AFT Pharmaceuticals rises on upbeat FY results
Brief: AFT Pharmaceuticals Sees FY25 Operating Profit Of NZ$22 Million To NZ$25 Million
Brief: AFT Pharmaceuticals Says FY Net Income NZD 15.6 Mln
Brief: AFT Pharmaceuticals Says Licensed Maxigesic IV In Brazil